These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39104058)

  • 1. The associations of supervised consumption services with the rates of opioid-related mortality and morbidity outcomes at the public health unit level in Ontario (Canada): A controlled interrupted time-series analysis.
    Robinson T; Farrokhyar F; Fischer B
    Drug Alcohol Rev; 2024 Nov; 43(7):1880-1891. PubMed ID: 39104058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using synthetic controls to estimate the population-level effects of Ontario's recently implemented overdose prevention sites and consumption and treatment services.
    Panagiotoglou D; Lim J
    Int J Drug Policy; 2022 Dec; 110():103881. PubMed ID: 36274565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the fentanyl patch-for-patch program in Ontario, Canada.
    Tadrous M; Greaves S; Martins D; Nadeem K; Singh S; Mamdani MM; Juurlink DN; Gomes T
    Int J Drug Policy; 2019 Apr; 66():82-86. PubMed ID: 30743092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cohort study of medical cannabis authorisation and healthcare utilisation in 2014-2017 in Ontario, Canada.
    Eurich D; Lee C; Zongo A; Minhas-Sandhu JK; Hanlon JG; Hyshka E; Dyck J
    J Epidemiol Community Health; 2020 Mar; 74(3):299-304. PubMed ID: 31831619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of Opioid Safety Efforts: Influence of Academic Detailing on Adverse Outcomes Among Patients in the Veterans Health Administration.
    Williams EC; Frost MC; Bounthavong M; Edmonds AT; Lau MK; Edelman EJ; Harvey MA; Christopher MLD
    Subst Use Addctn J; 2024 Oct; 45(4):610-623. PubMed ID: 38634339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between prescription opioid dispensing and opioid-related morbidity and mortality in Ontario, Canada: an ecological study of public health units.
    Ladha KS; Wijeysundera DN; Wunsch H; Clarke H; Diep C; Gomes T
    Drug Alcohol Depend; 2021 Oct; 227():108989. PubMed ID: 34482045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An individual-based dynamic model to assess interventions to mitigate opioid overdose risk.
    Gallant K; Lukeman R
    Harm Reduct J; 2024 Aug; 21(1):146. PubMed ID: 39135022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Montreal's supervised consumption sites on injection-related infections among people who inject drugs: An interrupted time series.
    Lim J; Panagiotoglou D
    PLoS One; 2024; 19(8):e0308482. PubMed ID: 39190638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-related emergency department visits and deaths after a harm-reduction intervention: a retrospective observational cohort time series analysis.
    Yeung MEM; Lee CH; Hartmann R; Lang E
    CMAJ Open; 2023; 11(3):E537-E545. PubMed ID: 37339791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An interrupted time series analysis of trends in opioid-related emergency department visits from pre-COVID-19 pandemic to pandemic, from the Canadian Hospitals Injury Reporting and Prevention Program.
    Yao X; McFaull SR; Champagne AS; Thompson W
    BMC Public Health; 2023 Aug; 23(1):1483. PubMed ID: 37537534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. At-a-glance - Hospitalizations and emergency department visits due to opioid poisoning in Canada.
    O'Connor S; Grywacheski V; Louie K
    Health Promot Chronic Dis Prev Can; 2018 Jun; 38(6):244-247. PubMed ID: 29911820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the COVID-19 pandemic: An interrupted time series study.
    Zolopa C; Brothers TD; Leclerc P; Mary JF; Morissette C; Bruneau J; Hyshka E; Martin NK; Larney S
    Int J Drug Policy; 2022 Dec; 110():103894. PubMed ID: 36308892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographic variation in the provision of naloxone by pharmacies in Ontario, Canada: A population-based small area variation analysis.
    Antoniou T; McCormack D; Campbell T; Sutradhar R; Tadrous M; Lum-Wilson N; Leece P; Munro C; Gomes T
    Drug Alcohol Depend; 2020 Nov; 216():108238. PubMed ID: 32891910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic in Ontario, Canada: A population-based analysis.
    Ledlie S; Tadrous M; Bayoumi AM; McCormack D; Cheng C; Besharah J; Munro C; Gomes T
    Int J Drug Policy; 2024 May; 127():104392. PubMed ID: 38522177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the population-level effects of overdose prevention sites and supervised consumption sites in British Columbia, Canada: Controlled interrupted time series.
    Panagiotoglou D
    PLoS One; 2022; 17(3):e0265665. PubMed ID: 35316284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Retrospective Cohort Study Comparing In-Person and Telemedicine-Based Opioid Agonist Treatment in Ontario, Canada, Using Administrative Health Data.
    Morin KA; Parrotta MD; Eibl JK; Marsh DC
    Eur Addict Res; 2021; 27(4):268-276. PubMed ID: 33706309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Small communities, large oversight': The impact of recent legislative changes concerning supervised consumption services on small communities in Ontario, Canada.
    Russell C; Imtiaz S; Ali F; Elton-Marshall T; Rehm J
    Int J Drug Policy; 2020 Aug; 82():102822. PubMed ID: 32563756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario.
    Gomes T; Kolla G; McCormack D; Sereda A; Kitchen S; Antoniou T
    CMAJ; 2022 Sep; 194(36):E1233-E1242. PubMed ID: 36122919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between recreational cannabis legalization and cannabis-related emergency department visits by age, gender, and geographic status in Ontario, Canada: An interrupted time series study.
    Kim C; Chum A; Nielsen A; Allin S; Penney TL; Rittenbach K; MacMaster FP; O'Campo P
    PLoS One; 2022; 17(10):e0268718. PubMed ID: 36288275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in alcohol-attributable hospitalisations and emergency department visits by age, sex, drinking group and health condition in Ontario, Canada.
    Smith BT; Schoer N; Sherk A; Thielman J; McKnight A; Hobin E
    Drug Alcohol Rev; 2023 May; 42(4):926-937. PubMed ID: 36843065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.